Ding and colleagues showed that, in Chinese patients with rheumatoid arthritis, low serum level of IL-34 (≤194.12 pg/ml) at baseline was a good predictor of response at 3-month following anti-TNF-α treatment [58]. The gene discussed is IL34; the disease is rheumatoid arthritis.